These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18708696)

  • 1. Use of an electrochemically synthesised metabolite of a selective androgen receptor modulator for mass spectrometry-based sports drug testing.
    Thevis M; Lohmann W; Schrader Y; Kohler M; Bornatsch W; Karst U; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):163-70. PubMed ID: 18708696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
    Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
    Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing.
    Thevis M; Lagojda A; Kuehne D; Thomas A; Dib J; Hansson A; Hedeland M; Bondesson U; Wigger T; Karst U; Schänzer W
    Rapid Commun Mass Spectrom; 2015 Jun; 29(11):991-9. PubMed ID: 26044265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for two selective androgen receptor modulators using gas chromatography-mass spectrometry in doping control analysis.
    Thevis M; Kohler M; Schlörer N; Fusshöller G; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):153-61. PubMed ID: 18708695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of selected in vitro generated phase-I metabolites of the steroidal selective androgen receptor modulator MK-0773 for doping control purposes.
    Lagojda A; Kuehne D; Krug O; Thomas A; Wigger T; Karst U; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2016; 22(2):49-59. PubMed ID: 27419898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product.
    Thevis M; Geyer H; Kamber M; Schänzer W
    Drug Test Anal; 2009 Aug; 1(8):387-92. PubMed ID: 20355219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
    Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
    Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes.
    Thevis M; Kamber M; Schänzer W
    Rapid Commun Mass Spectrom; 2006; 20(5):870-6. PubMed ID: 16470709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry of selective androgen receptor modulators.
    Thevis M; Schänzer W
    J Mass Spectrom; 2008 Jul; 43(7):865-76. PubMed ID: 18521833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens.
    Thevis M; Gerace E; Thomas A; Beuck S; Geyer H; Schlörer N; Kearbey JD; Dalton JT; Schänzer W
    Drug Test Anal; 2010; 2(11-12):589-98. PubMed ID: 20967890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105.
    Thevis M; Piper T; Beuck S; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1173-82. PubMed ID: 23650030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
    Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes.
    Thevis M; Thomas A; Fusshöller G; Beuck S; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2245-54. PubMed ID: 20623476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
    Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W
    Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control.
    Garg N; Hansson A; Knych HK; Stanley SD; Thevis M; Bondesson U; Hedeland M; Globisch D
    Org Biomol Chem; 2018 Jan; 16(5):698-702. PubMed ID: 29319101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry of hydantoin-derived selective androgen receptor modulators.
    Thevis M; Kohler M; Schlörer N; Kamber M; Kühn A; Linscheid MW; Schänzer W
    J Mass Spectrom; 2008 May; 43(5):639-50. PubMed ID: 18095383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.
    Thevis M; Kohler M; Maurer J; Schlörer N; Kamber M; Schänzer W
    Rapid Commun Mass Spectrom; 2007; 21(21):3477-86. PubMed ID: 17985352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARM-S4 and metabolites detection in sports drug testing: a case report.
    Grata E; Perrenoud L; Saugy M; Baume N
    Forensic Sci Int; 2011 Dec; 213(1-3):104-8. PubMed ID: 21816554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-depth metabolic study of nonsteroidal selective androgen receptor modulator GSK2881078 in thoroughbred horses and horse liver microsomes for doping control.
    Karatt TK; Sathiq MA; Laya S; Kal AKK; Subhahar MB; Muhammed Ajeebsanu MP; Philip M; Caveney MR; Graiban FM
    Drug Test Anal; 2023 Jul; 15(7):757-768. PubMed ID: 36922727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.